Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

622.P1.91 Non-Hodgkin’s Lymphoma - Biology, Excluding Therapy Poster I

Saturday, December 6, 2008: 5:30 PM-7:30 PM
Hall A (Moscone Center)
Absolute Lymphocyte Count at the Time of Relapse Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

Luis F. Porrata, MD*, Kay Ristow*, Thomas M Haberman, MD*, Thomas E Witzig, MD*, David James Inwards, MD, Stephen M Ansell, MD, PhD, Patrick B Johnston, MD, PhD, Ivana N. Micallef, MD*, Joseph P Colgan, MD*, William L White, MD* and Svetomir N Markovic, MD, PhD*

Department of Medicine/Division of Hematology, Mayo Clinic, Rochester, MN

Rac1 GTPase Targeting Inhibits p53-Deficiency Mediated Lymphomagenesis

Emily E Bosco, PhD*, James F Johnson*, Wenjun Ni* and Yi Zheng, PhD

Experimental Hematology, Cincinnati Childrens Hospital, Cincinnati, OH

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype

Blanca Espinet, PhD1*, Salaverría Itziar, PhD2*, Sílvia Beà, PhD2*, Neus Ruiz-Xivillé3*, Olga Balagué, MD4*, Marta Salido1*, Dolors Costa, PhD5*, Ana E Rodriguez6*, Juan LuíS. García, PhD6*, JesúS. M.ª Hernández-Rivas, MD, PhD6*, M.ª José Calasanz, PhD7*, Ana M Ferrer, MD, PhD1*, Antonio Salar, MD, PhD8*, Ana Carrió, PhD2*, Natividad Polo9*, Jose Antonio García-Marco, MD, PhD9*, Alicia Domingo, MD10*, Eva González-Barca, MD, PhD11*, Vicenç Romagosa, MD12*, Isabel Marugán13*, Armando López-Guillermo, MD, PhD14*, Fuensanta Millá, MD3*, José Luís Mate, MD, PhD15*, Elisa Luño, MD, PhD16*, Carmen Sanzo, MD, PhD16*, Rosa Collado, MD, PhD17*, Isabel Oliver17*, Sebastià Monzó, MD18*, Antonio Palacín, MD19*, Teresa González20*, Francesc Sant, MD21*, Ramon Salinas, MD, PhD22*, Mª Teresa Ardanaz, MD23*, Llorenç Font, MD, PhD24*, Lourdes Escoda, MD25*, Lourdes Florensa, MD, PhD1*, Elias Campo, MD, PhD4*, Sergi Serrano, MD, PhD1* and Francesc Solé, PhD1

1Pathology, Hospital del Mar, Barcelona, Spain
2Hematopathology Section-IDIBAPS, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
3Hematology, Hospital Germans Trias i Pujol, Badalona, Spain
4Pathology, Hospital Clínic, Barcelona, Spain
5Hematopathology Section-IDIBAPS, Hospital Clínic, Universitat de Barcelona, Barcelona
6Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
7Genetics, Universidad de Navarra, Pamplona, Spain
8Hematology, Hospital del Mar, Barcelona, Spain
9Hematology, Hospital Universitario Puerta de Hierro, Madrid, Spain
10Hematology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain
11Hematology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain
12Pathology, Hospital Universitari de Bellvitge, Spain
13Hematology and Oncology, Hospital Clínico Universitario, Valencia, Spain
14Hematology, Hospital Clínic, Barcelona, Spain
15Pathology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
16Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain
17Hematology, Consorcio Hospital General Universitario, Valencia, Spain
18Hematology, Hospital Universitari Sagrat Cor, Barcelona, Spain
19Pathology, Hospital Universitari Sagrat Cor, Barcelona, Spain
20Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
21Pathology, Althaia. Xarxa Assistencial de Manresa, Manresa, Spain
22Hematology, Althaia. Xarxa Assistencial de Manresa, Manresa, Spain
23Hematology, Hospital Txagorritxu, Vitoria, Spain
24Hematology, Hospital Verge de la Cinta., Tortosa, Spain
25Hematology, Hospital Joan XXIII, Tarragona, Spain

Proteomic Analysis of Chronic Malignant B-Cell Derived Microparticles Reveals CD148 as a Potential Antigenic Marker for Mantle Cell Lymphoma Diagnosis

Laurent Miguet1*, Luc-Matthieu Fornecker2*, Claire Felden3*, Carine Gervais4*, Raoul Herbrecht, MD2, Sarah Sanglier1*, Alain van Dorsselaer1* and Laurent Mauvieux, MD, PhD3

1Laboratoire de Spectrométrie de Masse Bio-Organique, CNRS, UMR7178, Strasbourg, France
2Oncology and Hematology, Hopital de Hautepierre, Strasbourg Cedex, France
3Laboratoire d'Hematologie Cellulaire, Faculté de Médecine de Strasbourg, Strasbourg, France
4Laboratoire d'Hématologie, Hopitaux universitaires de Strasbourg, Strasbourg, France

Targeting CDK4 in Mantle Cell Lymphoma (MCL) Cell Lines by Specific Lentiviral shRNA Mediated Knockdown Has Profound Effects on Cell Growth and Cell Cycle but Minimal Effects on Apoptosis

Margit Klier1*, Irina Bonzheim, PhD1*, Natasa Anastasov, PhD2*, Daniela Angermeier3*, Mark Raffeld, MD4, Falko Fend, MD1* and Leticia Quintanilla-Martinez, MD1*

1Pathology, University Hospital Tuebingen, Eberhard-Karls-University, Tuebingen, Germany
2Radiation Biology, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany
3Pathology, Technical University Munich, Muenchen, Germany
4National Cancer Institute, NIH, Bethesda, MD

Prognostic Value of Angiogenic Factors (Vacular Endothelial Growth Factor [VEGF] and Basic Fibroblast Growth Factor [bFGF]) and Endostatin in Patients with Non-Hodgkin Lymphoma

Jean Abou Yared, MD1*, Theodore Girinsky, MD2*, Serge Koscielny, PhD3*, Vincent Ribrag, MD4, Patrice Carde, MD4*, Suzanna Ceapa, MD2* and Christophe Ferme, MD4*

1Internal Medicine, Greater Baltimore Medical Center, Baltimore, MD
2Dept. of Radiation Oncology, Institut de Cancerologie Gustave Roussy, Villejuif, 94805, France
3Dept. of Biostatistics, Institut de Cancerologie Gustave Roussy, Villejuif, 94085, France
4Dept. of Medicine, Institut de Cancerologie Gustave Roussy, Villejuif, France

Genome Wide Analysis of 41 Mycosis Fungoides Tumor Stage Using Array Comparative Genomic Hybridization Technology

Rocio Salgado, Bs1*, Octavio Servitje, MD, PhD2*, Fernando Gallardo, MD, PhD3*, Maarten H Vermeer, MD, PhD4*, Pablo Ortiz Romero, MD, PhD5*, Marta Herrera, MD5*, Maria Karpova, PhD6*, Cristina Muniesa, MD7*, M. Pilar García-Muret, MD, PhD8*, Teresa Estrach, MD, PhD9*, Julia Sánchez-Schmidt, MD3*, Vicenç Romagosa, MD10*, Marie Zipser, MD6*, Javier Suela, PhD11*, Bibiana I Ferreira, Bs12*, Juan Cigudosa, PhD12, Carlos Barranco, MD, PhD1*, Reinhard Dummer, MD, PhD6*, Cornelis P Tensen, MD4*, Sergi Serrano, MD, PhD1*, Ramon M Pujol, MD, PhD3*, Francesc Solé, PhD13 and Blanca Espinet, PhD1*

1Pathology, Hospital del Mar, Barcerlona, Spain
2Dermatology, Hospital Universitario de Bellvitge, L´Hospitalet de Llobregat, Barcelona, Spain
3Dermatology, Hospital del Mar, Barcelona, Spain
4Dermatology, Leiden University Medical Center, Leiden, Netherlands
5Dermatology, Hospital 12 de Octubre, Madrid, Spain
6Dermatology, University Hospital Zurich, Zurich, Switzerland
7Dermatology, Hospital de Viladecans, Viladecans, Barcelona, Spain
8Dermatology, Hospital de Sant Pau, Barcelona, Spain
9Dermatology, Hospital Clinic, Barcelona, Spain
10Pathology, Hospital Universitari de Bellvitge, Spain
11NIMGenetics, Tres Cantos, Madrid, Spain
12Cytogenetics Unit, CNIO, Madrid, Spain
13Pathology, Hospital del Mar, Barcelona, Spain

Incidence and  Clinicopathological Relevance of Gene Copy Number Abnormalities Detected by a Single Quantitative PCR Assay in Mantle Cell Lymphomas

Fabrice Jardin*, Jean-Michel Picquenot*, Francoise Parmentier*, Marie Cornic*, Sandrine Vaudaux*, Philippe Ruminy*, Dominique Penther*, Helene Lanic*, Ophelie Cassuto*, Vincianne Rainville*, Christian Bastard* and Herve Tilly

Hematology, INSERM U918, Centre Henri Becquerel, Rouen, France

Deletions of Chromosomes 6q and 13q, and Trisomy 4 Are the Most Common Cytogenetic Abnormalities in Waldenstrom Macroglobulinemia. Preliminary Results of a Multicentric Study

Florence Nguyen-Khac, MD, PhD1*, Elise Chapiro1*, Sarah Mould2*, Carole Barin3*, Agnes Daudignon4*, Nathalie Gachard5*, Stéphanie Struski6*, Catherine Henry7*, Dominique Penther8*, Hossein Mossafa9, Joris Andrieux10*, Bernard Perissel11*, Virginie Eclache12*, Chrystele Bilhou-Nabera13*, Isabelle Luquet, MD, PhD14*, Christine Terre15*, Laurence Baranger16*, Francine Mugneret17*, Marie-Jose Gregoire18*, Jean Chiesa19*, Sylvie Ramond20*, Marie-Joelle Mozziconacci21*, Evelyne Callet-Bauchu22*, Helene Merle-Beral1 and Veronique Leblond1*

1Hopital Pitie-Salpetriere, Paris, France
2Royal Bournemouth Hospital, United Kingdom
3Hopital de Tours
4Hopital de Valenciennes
5Hopital de Limoges
6Hopitaux Universitaires de Strasbourg
7Hopital de Rennes
8Centre Henri Becquerel, Rouen
9Cerba-Pasteur
10Hopital de Lille
11Hopital de Clermont-Ferrand
12Hopital Avicenne
13Hopital Kremlin-Bicetre
14Laboratoire central d'Hématologie, Hôpital Robert Debré, Reims, France
15CH de Versailles
16Hopital d'Angers
17Hopital de Dijon
18Hopital de Nancy
19Hopital de Nimes
20Hopital Hotel-Dieu, Paris
21IPC, Marseille, Marseille, France
22Cytogenetic Laboratory, Hopital Lyon-Sud, Pierre Bénite, France

Low Ratio of Inter-Follicular CD8/FOXP3-Positive Regulatory T-Cells Is Associated with a favourable Overall Survival in Follicular lymphoma (FL)

Majda Saifi1*, Mounia Braza2*, ThéR.èse Rousset3*, Valérie Costes4* and Jean-Francois Rossi5

1Pathology, University Hospital, Montpellier 34295 cedex5, France
2Inserm U847, Institute of Biotherapy, Montpellier cedex5, France
3Pathology, University Hospital, 34295 Montpellier cedex5, France
4Pathology, University Hospital and INSERM U847, Montpellier cedex5, France
5Hematology-Oncology, Chu Lapeyronie, Montpellier, France

In Follicular Lymphoma (FL), γδt-Lymphocytes (γδT) Are Present and Expandable from Peripheral Blood and Rare in Tumour Lymph Nodes, Mostly in Peri-Follicular Areas

Mounia Braza1*, Therese Rousset2*, Majda Saifi3*, Guillaume Cartron4*, Sylvie Lafaye de Micheaux5*, Helene Sicard6*, Patrick Squiban5*, Valérie Costes7* and Jean-Francois Rossi8

1Inserm U847, Institute of Biotherapy, Montpellier cedex5, France
2Pathology, University Hospital, 34295 Montpellier cedex 5, France
3Pathology, University Hospital, Montpellier 34295 cedex5, France
4Haematology-Oncology, INSERM U847 and CIC BT 509, University Hospital, Montpellier Cedex 5, France
5Medical Department, Innate Pharma, Marseille, France
6Research and Development, Innate Pharma, Marseille, France
7Pathology, University Hospital and INSERM U847, Montpellier cedex5, France
8Hematology-Oncology, Chu Lapeyronie, Montpellier, France

Proteomic Analysis for the Identification of Disease Biomarkers and Therapeutic Targets in Natural Killer Cell Lymphoma

Hojung Lee1*, Evan Shereck2*, Mitchell S. Cairo2, Seiler E Seiler III1*, Venkatesha Basrur1*, Damian Fermin1*, Kojo SJ Elenitoba-Johnson1 and Megan S Lim1

1Department of Pathology, University of Michigan Health Medical School, Ann Arbor, MI
2Department of Pediatrics, Pathology and Medicine, Morgan Stanley Children's Hospital of New-York Presbyterian, Columbia University, New York City, NY

Splenic Marginal Zone B-Cell Lymphoma: Clinical Clustering of Immunoglobulin Heavy Chain Repertoires

Silvia Zibellini1*, Luca Arcaini1*, Francesco Passamonti1*, Sara Rattotti1*, Marco Lucioni, MD2*, Rosangela Invernizzi3*, Cristina Picone1*, Elisa Rumi1*, Michele Merli1*, Silvia Rizzi1*, Emanuela Boveri4*, Marzia Varettoni, MD1*, Cristiana Pascutto1*, Marco Paulli4* and Mario Lazzarino1*

1Division of Hematology, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy
2Patologia Umana ed Ereditaria, Sezione di Anatomia Patologica, Fondazione IRCCS Policlinico S. Matteo e Università di Pavia, Pavia, Italy
3Department of Internal Medicine, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy
4Department of Pathology, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy

Outcomes and a New Prognostic Model in Posttransplantation Lymphoproliferative Disorders (PTLD):  Intent-to-Treat (ITT) Analysis of 81 Patients in the Post-Rituximab Era

Andrew M. Evens, DO, MS1, Kevin A. David, MD1*, Irene Helenowski, PhD1*, Sheetal M. Kircher, MD2*, Lauren Mauro, MD1*, Alla Gimelfarb, MD3*, Koen Van Besien, MD2*, Elise Hattersley, MD4*, Beverly P Nelson, MD5*, Jayesh Mehta, MD1*, Leo I. Gordon, MD1*, Jamile M. Shammo, MD, FASCP3*, Scott E. Smith, MD, PhD4 and Sonali Smith, MD2

1Hematology/Oncology, The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
2University of Chicago, Chicago, IL
3Hematology, Rush University Medical Center, Chicago, IL
4Loyola Univ. Med. Ctr., Maywood, IL
5Pathology, The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL

Family History of Cancer and Risk of Lymphoma: Influence of IL8RB, GGH IVS7 and IL10 Polymorphisms

Eva Domingo-Domènech, MD1*, Yolanda Benavente2*, Carlos Montalbán, PHD3*, Ramon Bosch, MD4*, Josep Gumà, MD5*, Sophia Wang6*, Nathaniel Rothman6*, Eva Gonzalez-Barca1* and Silvia de Sanjose, MD, PhD2*

1Hematology, Institut Catala d'Oncologia, L'Hospitalet de Llobregat, Spain
2Unit of Infections and Cancer, CIBERESP, Idibell, Institut Catala d'Oncologia
3Internal Medicine, Hospital Ramon y Cajal
4Pathology, Hospital Verge de la Cinta
5Oncology, Hospital Sant Joan de Reus
6Division of Cancer Epidemiology and Genetics, National Cancer Institute

IgG-Secreting B-Cell Lymphoplasmocytoid Leukaemia : Molecular Characterization of Igh Rearrangements

Laurence Lode1*, Surinder S. Sahota, PhD2*, Soraya Wuilleme1*, Steven Richebourg1*, Marion Eveillard1*, Regis Bataille3*, Herve Avet Loiseau, MD, PhD1 and Richard Garand, MD1*

1Laboratoire d'Hematologie, CHU Nantes, Nantes, France
2Molecular immunology group, Tenovus laboratory, Southampton university hospitals, Southampton
3Centre de Lutte contre le Cancer Nantes Atlantique

CS-1 Is Expressed in Nasal Type NK/T Cell Lymphomas and Angioimmunoblastic T-Cell Lymphomas: Implications for Targeted Therapy with Elotuzumab (HuLuc63)

Eric D Hsi, MD1, Roxanne Steinle1*, Balaji Balasa2*, Audie Rice, PhD2*, Young-Hyeh Ko, MD3* and Daniel E.H. Afar, PhD2*

1Clinical Pathology, Cleveland Clinic, Cleveland, OH
2PDL Biopharma, Redwood City, CA
3Pathology, Samsung Medical Center, Seoul, South Korea

Indolent Mantle Cell Lymphoma (MCL): A Retrospective Detailed Clinical and Morphological Analysis of 21 Patients, with Histological, Cytological, Cytogenetic, Interphase Genetic, Immunoglobulin Gene, and Gene Expression Profiling Analysis

Catherine Thieblemont1, Remi Houlgatte2*, Pascale Felman3*, Alexandra Traverse-glehen4*, Lucile Baseggio3*, Delphine Rolland5*, Evelyne Callet-Bauchu6*, Gilles Salles7, Francoise Berger8* and Bertrand Coiffier9

1Hemato-Oncology, Hopital Saint-Louis, APHP - INSERM U 728 - Institut Universitaire d'Hematologie, Paris, France
2INSERM U533 - Institut du thorax - Faculté de Médecine, Université de Nantes, Nantes, France
3Hematologie biologique, Hospices Civils de Lyon, Centre hospitalier Lyon Sud, Pierre-Benite, France
4Anatomie pathologique, Hospices Civils de Lyon, Centre hospitalier Lyon Sud - Université Lyon 1, Equipe d'Accueil 3737, Pierre-Bénite, France
5INSERM U836 Equipe 7 - Faculte de Medecine, Universite J. Fourier, Grenoble, France
6Cytogenetic Laboratory, Hopital Lyon-Sud, Pierre Bénite, France
7Hematologie, Centre Hospitalier Lyon-Sud, Pierre-Benite, France
8Anatomie pathologique, Hospices Civils de Lyon, Centre hospitalier Lyon Sud - Université Lyon 1,, Pierre-Bénite, France
9Hematologie, Centre Hospitalier Lyon-Sud, Pierre-Benite

Clinical Significance of CD21 Co-Expressed with LFA-1 in Non-Hodgkin’s B-Cell Lymphoma

Kazushi Tanimoto, MD1*, Yoshihiro Yakushijin, MD, PhD2*, Hiroshi Fujiwara, MD, PhD1, Masaki Otsuka, MD, PhD1*, Koichi Ohshima, MD, PhD3*, Atsuro Sugita, MD, PhD4*, Akira Sakai, MD, PhD5, Takaaki Hato, MD, PhD6, Hitoshi Hasegawa, MD, PhD1* and Masaki Yasukawa, MD, PhD1

1Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan
2Cancer center of Ehime University Hospital, Ehime University Graduate School of Medicine, Toon, Japan
3Department of Pathology, Kurume University School of Medicine, Kurume, Japan
4Department of Pathology of Ehime Universty Hospital, Ehime University Graduate School of Medicine, Toon, Japan
5Hiroshima University, Hiroshima, Japan
6Div. of Blood Transfusion, Ehime University, Toon, Japan

Clinicopathologic Analysis of Primary Gastrointestinal T-Cell Lymphoma with a Special Reference to Intestinal and Gastric Type in Japan

Hideko Yamamoto1*, Keitaro Matsuo2*, Hidemi Goto3* and Shigeo Nakamura, MD4

1Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan., Nagoya-City, Japan
2Division of Epidemiology and Prevention, Aichi Cancer Center, Nagoya, Japan
3Department of Gastroenteralogy, Nagoya University Graduate School of Medicine, Nagoya, Japan., Nagoya-City, Japan
4Pathology & Clin. Labs., Nagoya Univ. Hospital

Vitamin D, Sun Exposure, and Lymphoma Risk

Jennifer L. Kelly, PhD, MPH1, Jonathan W. Friedberg, MD, MMSc2*, Laura M. Calvi, MD3*, Edwin van Wijngaarden, PhD1* and Susan G. Fisher, MS, PhD1*

1Community & Preventive Medicine, University of Rochester, Rochester, NY
2James P. Wilmot Cancer Center, University of Rochester, Rochester, NY
3Endocrine Metabolism Division, Medicine, University of Rochester, Rochester, NY

A Critical Analysis of Prognostic Factors in Patients with HTLV-1 Adult T-Cell Leukemia/Lymphoma: A Multicenter Clinicopathologic Experience and New Prognostic Score

Adrienne A. Phillips, MD, MPH1, Iuliana Shapira, MD2, Robert D. Willum, BS1*, Jasotha Sanmugarajah, MD3*, William B. Solomon, MD3, Steven M. Horwitz, MD4, David G. Savage, MD1*, Govind Bhagat, MD5*, Gerald Soff, MD3*, Jasmine M. Zain, MD1*, Bashir Alobeid, MD5*, Venkatraman E. Seshan, PhD6* and Owen A. O'Connor, MD, PhD1*

1Division of Medical Oncology, Herbert Irving Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY
2Monter Cancer Center, North Shore University Hospital, Lake Success, NY
3Department of Hematology-Oncology, SUNY Downstate Medical Center, Brooklyn, NY
4Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
5Department of Pathology, Herbert Irving Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY
6Department of Biostatistics, Herbert Irving Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY

Cutaneous Lymphocyte Antigen and TRAF-1 Are Useful in Differentiating Lymphomatoid Papulosis, Cutaneous ALCL and Systemic ALCL

Dorna Rezania, MD1*, Elizabeth Sagatys, MD2*, L. Frank Glass, MD3*, Marshall E. Kadin, MD4* and Hernani Cualing, MD5

1Genoptix Medical Laboratory, Carlsbad, CA
2Pathology, Moffitt Cancer Center, Tampa, FL
3Cutaneous Oncology Program, Moffitt Cancer Center, Tampa, FL
4Dermatology, Roger Williams Hospital, Boston University Medical Center, Providence, RI
5Pathology, H. Lee Moffitt Cancer Center, Tampa, FL

Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV

Sarah T Wilkinson, PhD1*, Diane R Fernandez, MD1*, Shawn P Murphy, PhD2*, Wing C. Chan, MD3, Randy D. Gascoyne, MD4, Elias Campo, MD5*, Elaine S. Jaffe, MD6, Louis M. Staudt, MD, PhD6, Jan Delabie, MD, PhD7*, Andreas Rosenwald, MD8* and Lisa M Rimsza, MD1

1Pathology, University of Arizona, Tucson, AZ
2University of Rochester School of Medicine and Dentistry, Rochester, NY
3University of Nebraska Medical Center, Omaha, NE
4British Columbia Cancer Agency, Vancouver, BC, Canada
5University of Barcelona, Barcelona, Spain
6National Cancer Institute, Bethesda, MD
7Radium Hospital, Oslo, Norway
8University of Würzburg, Würzburg, Germany

Expression of CD20 but Not EBV Is Associated with Significantly Improved Overall (OS) and Event Free Survival (EFS) in Children with Post Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplantation (SOT)

Manuela A. Orjuela, MD1*, Bachir Alobeid2*, Xinhua Liu3*, Aisha L. Siebert4*, Emily R. Kott4*, Linda J. Addonizio5*, Erin Morris5*, James H. Garvin Jr., MD5*, Steven J. Lobritto, MD5* and Mitchell S. Cairo, MD6*

1Pediatrics and Environmental Health Sciences, Columbia University, New York, NY
2Pathology, Columbia University College of Physicians and Surgeons, New York, NY
3Biostatistics, Columbia University, New York, NY
4Environmental Health Sciences, Columbia University, New York, NY
5Pediatrics, Columbia University, New York, NY
6Pediatrics, Medicine, Pathology, Columbia University Med. Ctr., New York, NY

*signifies non-member of ASH